Clinical Trials Sponsored by ProtAffin Biotechnologie AG

Total 30 results

ProtAffin Biotechnologie AG

Terminated

A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401

Healthy Volunteers

United Kingdom
Cytos Biotechnology AG

Withdrawn

CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids

Asthma

United States
Cytos Biotechnology AG

Completed

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

House Dust Mite Allergy | Perennial Allergic Rhinoconjunctivitis

Switzerland
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients

Malignant Melanoma

Switzerland
Cytos Biotechnology AG

Terminated

CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma

Moderate to Severe Allergic Asthma

United States, Czech Republic, Germany, Hungary, Israel, Poland, Russian Federation, Ukraine
Cytos Biotechnology AG

Completed

Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb

Essential Hypertension
Cytos Biotechnology AG

Completed

Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

Rhinoconjunctivitis | Allergies

Estonia, Germany, Greece, Latvia, Lithuania, Romania
Cytos Biotechnology AG

Completed

Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension

Hypertension

Switzerland, Germany
Cytos Biotechnology AG

Completed

Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy

Allergic Asthma | Perennial Allergic Rhinoconjunctivitis

Switzerland
Cytos Biotechnology AG

Completed

Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy

Hypersensitivity

Switzerland
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Melanoma

Germany
Cytos Biotechnology AG

Completed

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

House Dust Mite Allergy | Perennial Allergic Rhinoconjunctivitis
Cytos Biotechnology AG

Completed

Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany, Switzerland
Cytos Biotechnology AG

Completed

CYT003-QbG10 for Treatment of Allergic Asthma Bronchial

Allergic Bronchial Asthma

Germany
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Cytos Biotechnology AG

Completed

Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers

Smokers

Switzerland
Cytos Biotechnology AG

Completed

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Mild Essential Hypertension | Moderate Essential Hypertension

Switzerland
Cytos Biotechnology AG

Completed

Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Perennial Allergy to House Dust Mite and/or Cat

Estonia, Latvia, Lithuania
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
AVIR Green Hills Biotechnology AG

Completed

Dose Finding Study of Single Dose GHB11L1 in Healthy Adults (GHB-CS07)

Influenza, Human

Austria
AVIR Green Hills Biotechnology AG

Completed

Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers (GHBCS-01)

Seasonal Human Influenza

Austria
AVIR Green Hills Biotechnology AG

Completed

Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults

Influenza, Avian

Russian Federation
AVIR Green Hills Biotechnology AG

Completed

Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults

Influenza, Human

Austria
University Medical Centre Ljubljana
Innovacell Biotechnologie AG

Completed

Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence

Stress Urinary Incontinence

Slovenia
RepliCel Life Sciences, Inc.
Syreon Corporation; Innovacell Biotechnologie AG

Terminated

Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis (ReaCT)

Tendinopathy | Tendinosis

Canada
Orion Biotechnology Polska Sp. z o.o.
Scope International AG

Completed

OB-002H Gel Administered Vaginally and Rectally in HIV-1 Seronegative Adults

HIV Prevention

Poland
AVIR Green Hills Biotechnology AG
Medical University of Vienna

Completed

Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults (GHB-CS03)

Influenza

Austria
RepliCel Life Sciences, Inc.
Syreon Corporation; Innovacell Biotechnologie AG; PHARMALOG Institut für klinische... and other collaborators

Completed

Study of Intradermal Injections of RCS-01 in Male and Female Subjects

Intrinsic Aging of Skin | Skin Wrinkling | Solar Degeneration of Skin

Germany
TrichoScience Innovations, Inc.
PRA Health Sciences; Pharmalog Institut für klinische Forschung GmbH (PHARMALOG... and other collaborators

Completed

Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia

Androgenetic Alopecia

Georgia
National Institute of Allergy and Infectious Diseases...
Eli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); Gla... and other collaborators

Completed

ACTIV-3: Therapeutics for Inpatients With COVID-19 (TICO)

Covid19

United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom

Clinical Trials Sponsored by ProtAffin Biotechnologie AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations